AstraZeneca Will Pay $5.5M To SEC Over FCPA Claims
AstraZeneca PLC agreed Tuesday to pay $5.5 million to the U.S. Securities and Exchange Commission to settle claims it violated the Foreign Corrupt Practices Act through improper payments by overseas sales...To view the full article, register now.
Already a subscriber? Click here to view full article